Anna-Lena Spetz

Company: TIRmed Pharma
Job title: Chief Scientific Officer & Founder
Seminars:
Immunoregulatory Oligonucleotide for the Treatment of Mild- Moderate Atopic Dermatitis. 11:15 am
Developing a non-steroid topical treatment in a small biotech:-possibilities and challenges Inducing immunoregulatory type immune responses in the skin to enhance preclinical modelling Reducing certain itch responses by an immunoregulatory oligonucleotideRead more
day: Day One